Basis of Presentation - Changes to Impacted Consolidated Statements of Operations (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Total Sales	$ 3,426,823	$ 3,018,774	$ 8,937,633	$ 9,850,702
Total Cost of Sales	2,558,602	2,622,812	7,328,335	8,330,733
Gross Profit (exclusive of depreciation shown separately below)	868,221	395,962	1,609,298	1,519,969
Operating Expenses:
Research and Development	3,440,685	3,397,118	9,540,272	8,326,431
Selling and Marketing	1,980,748	1,653,013	5,895,332	4,305,632
General and Administrative	4,854,014	5,463,247	15,307,242	16,672,046
Depreciation and Amortization	510,099	246,902	1,149,046	731,035
Loss on Fixed Asset Disposal				83,908
Impairment of Patents and Trademarks	48,075	7,544	97,676	66,040
Total Operating Expenses	10,833,621	10,767,824	31,989,568	30,185,092
Loss From Operations	(9,965,400)	(10,371,862)	(30,380,270)	(28,665,123)
Total Other Expense	488,401	(115,686)	375,603	(219,267)
Net Loss	$ (9,476,999)	$ (10,487,548)	$ (30,004,667)	$ (28,884,390)
Basic Loss per Common Share	$ (0.15)	$ (0.17)	$ (0.47)	$ (0.48)
Diluted Loss per Common Share	$ (0.15)	$ (0.17)	$ (0.47)	$ (0.48)
Previously Reported [Member]
Total Sales		$ 3,018,774		$ 9,850,702
Total Cost of Sales		2,435,437		7,608,401
Gross Profit (exclusive of depreciation shown separately below)		583,337		2,242,301
Operating Expenses:
Research and Development		3,270,255		8,050,915
Selling and Marketing		1,589,582		4,167,874
General and Administrative		3,112,059		11,565,816
Depreciation and Amortization		434,277		1,453,367
Loss on Fixed Asset Disposal				83,908
Impairment of Patents and Trademarks		7,544		66,040
Total Operating Expenses		8,413,717		25,387,920
Loss From Operations		(7,830,380)		(23,145,619)
Total Other Expense		(115,686)		(219,267)
Net Loss		$ (7,946,066)		$ (23,364,886)
Basic Loss per Common Share		$ (0.13)		$ (0.39)
Diluted Loss per Common Share		$ (0.13)		$ (0.39)
Revision of Prior Period, Error Correction, Adjustment [Member]
Operating Expenses:
Research and Development		$ 126,863		$ 275,516
Selling and Marketing		63,431		137,758
General and Administrative		2,351,188		5,106,230
Total Operating Expenses		2,541,482		5,519,504
Loss From Operations		(2,541,482)		(5,519,504)
Net Loss		$ (2,541,482)		$ (5,519,504)
Basic Loss per Common Share		$ (0.04)		$ (0.10)
Diluted Loss per Common Share		$ (0.04)		$ (0.10)
Revision of Prior Period, As Restated [Member]
Total Sales		$ 3,018,774		$ 9,850,702
Total Cost of Sales		2,435,437		7,608,401
Gross Profit (exclusive of depreciation shown separately below)		583,337		2,242,301
Operating Expenses:
Research and Development		3,397,118		8,326,431
Selling and Marketing		1,653,013		4,305,632
General and Administrative		5,463,247		16,672,046
Depreciation and Amortization		434,277		1,453,367
Loss on Fixed Asset Disposal				83,908
Impairment of Patents and Trademarks		7,544		66,040
Total Operating Expenses		10,955,199		30,907,424
Loss From Operations		(10,371,862)		(28,665,123)
Total Other Expense		(115,686)		(219,267)
Net Loss		$ (10,487,548)		$ (28,884,390)
Basic Loss per Common Share		$ (0.17)		$ (0.48)
Diluted Loss per Common Share		$ (0.17)		$ (0.48)